Browsing ODA Open Digital Archive by Author "Helm, Thea Elisabeth"

Now showing items 1-1 of 1

Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study

Helm, Thea Elisabeth; Høivik, Marte Lie; Anisdahl, Karoline; Buer, Lydia Celine Tansem; Warren, David; Bolstad, Nils; Småstuen, Milada Cvancarova; Moum, Bjørn Allan; Medhus, Asle Wilhelm (Peer reviewed; Journal article, 2024)

Background: Vedolizumab has since 2021 been available as a subcutaneous formulation. We aimed to assess 18-month drug persistence and possible predictive factors associated with discontinuation, safety, serum drug profile, ...